Global OSA Institute: Closing Gaps, Advancing Outcomes in Mixed-Access Systems
Learning objectives
Upon completion of this activity, participants should be able to:
- Integrate OSA diagnosis into cardiometabolic risk assessment and management through screening of high-risk patients and coordinated cardiometabolic care.
- Implement evidence-based, multimodal OSA treatment plans that integrate PAP therapy, cardiometabolic management, and emerging pharmacotherapy, applying a multidisciplinary, chronic-disease model
- Implement simplified, accessible diagnostic algorithms and integrated obesity-CVD-OSA care pathways to overcome diagnostic bottlenecks, reduce care fragmentation, and improve timely access to evidence-based treatment for patients with moderate-to-severe OSA across diverse healthcare settings
This is an infographic summary of a presentation by Dr. Reena Mehra, which you can find here. Before watching, please read our information on CME credits and conflict of interest disclosures, which you can find here.
This program is supported by an independent educational grant from Lilly. This education program is designed for healthcare professionals globally (excluding the UK).
Content correct at the time of publication.